Among the foremost challenges facing cannabidiol (CBD) consumers is finding brands that offer consistently high-quality products. This is because, as of yet, there are no established industry production standards, which allows widely different techniques and substantial variance, in terms of purity and potency.
CBD is found in cannabis and hemp plants, and has long been used for its medicinal benefits. Unlike tetrahydrocannabinol (THC) - the compound in cannabis that results in a consumer feeling 'high' - CBD has no psychoactive effects.
Since most CBD consumers are seeking a specific and consistent medicinal outcome, reducing or eliminating quality and potency variances in production is critical. By adhering to strict, multitiered production standards, a CBD producer can ensure that it maintains and delivers what those consumers are seeking.
According to Boris Blatnik, the chief strategy officer at KannaSwiss, crafting CBD products of consistent high quality is a matter of implementing a production process that cuts no corners. At KannaSwiss, that means considering every step - from seed to shelf.
The company starts by selecting mother plants that contain the highest levels of health-promoting cannabinoids and terpenes, and then growing subsequent generations using the best in holistic care. KannaSwiss uses organic solutions to maximise growth potential, which lays the foundation for the CBD production process to come.
While there are many extraction methods to choose from, each with its own pros and cons, KannaSwiss has committed to the process of ethanol extraction. This technique enables the company to extract every valuable compound from the plant; it is a much more demanding process, but the end result speaks for itself, with a higher cannabinoid count.
It's important for CBD producers to keep in mind that consumers are searching for products that address an array of health issues - they are patients just as much as clients.
KannaSwiss, therefore, pays attention to the retention of key health-promoting elements. After extraction, the process of chromatography is used to separate THC from the other cannabinoids. After this step, CBD, cannabichromene, cannabigerol and cannabinol, along with terpenes, vitamin E, and healthy fatty acids, are left intact.
Blatnik says that the KannaSwiss team is strictly opposed to taking shortcuts. "In fact, we go an extra step by putting our extract through a short-path destination system to make sure any leftover impurities are taken out," he explains. "The final product that comes out of our short path is 100% cannabinoids. The look and consistency of the distillate is of a pure, golden honey. This is the kind of attention to detail that you usually see put into small-batch products, but at KannaSwiss, we believe that it's worth the effort to put small-batch care into large-scale production - the end products speak for themselves."
Finally, before KannaSwiss products hit the shelf, they are outfitted in packaging that has been carefully designed to present a contemporary, sophisticated and soothing aesthetic. This is essential for presenting consumers with a product they can trust.
KannaSwiss began producing CBD oil in 2014, releasing its first commercial batch in 2016. Since then, it has expanded its offerings to several lines of CBD tinctures, water-soluble drops, vape pens, symptom-specific supplements, transdermal creams and more. Plus, the company is looking into releasing more products - each with the same attention to quality.
"We believe that our craft-detailed production processes will help set the standard for quality within the CBD space," says Blatnik. "Not only are we working to expand and improve upon our own products and their bioavailability, but we're also committed to doing our part when it comes to growing the CBD market to its fullest potential."
As KannaSwiss persists at refining its production processes and developing new CBD offerings, the cannabis and hemp industry will continue to evolve and grow. By establishing itself among leaders in quality cannabinoid production, KannaSwiss is positioned to seize emerging opportunities, and branch out as regulations change and new markets open.